Buprenorphine And Naloxone 03215-6523
Product NDC
03215-6523- Manufacturer
- Aveva Drug Delivery Systems Inc.
- Dosage Form
- Film
- Route
- Buccal And Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- August 29, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA212756
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
| Naloxone Hydrochloride | 2 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Packaging Options(1)
30 POUCH in 1 CARTON (3215-6523-30) / 1 FILM in 1 POUCH (3215-6523-01)